References
- Clinical Synthesis Panel on HRT. Hormone replacement therapy. Lancet 1999;354:152–5
- Keating NL, Cleary PD, Rossi AS, Zaslavsky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999;130:545–53
- MacLennan AH, Wilson DH, Taylor AW. Hormone replacement therapy: prevalence, compliance and the 'healthy women' notion. Climacteric 1998;1:42–9
- North FM, Sharples K. Changes in the use of hormone replacement therapy in New Zealand from 1991-1997. NZ Med J 2001;114:250–3
- Moorhead T, Hannaford P, Warskyj M. Preva-lence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol 1997;104:290–7
- Harris TJ, Cook DG, Wicks PD, Cappuccio FP. Ethnic differences in use of hormone replacementtherapy: community based survey. Br Med J 1999;319:610–11
- Manson JE, Martin KA. Postmenopausal hormone-replacement therapy. N Engl J Med 2001;345:34–40
- Shah S, Harris TJ, Cook DG. Differences in hormone replacement therapy use by social class, region and psychological symptoms. Br J Obstet Gynaecol 2001;108:269–75
- Duetz MS, Abel T, Meier C, Niemann S. Self-rated health, life satisfaction and personal characteristics of postmenopausal women under estrogen replacement therapy. Maturitas 2000; 35:71–9
- Connelly MT, Richardson M, Platt R. Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990–1995. J Gen Intern Med 2000;15: 542–50
- Finley C, Gregg EW, Solomon u, Gay E. Dis-parities in hormone replacement therapy use by socio-economic status in a primary care popula-tion. Community Health 2001;26:39–50
- Blumberg G, Kaplan B, Rabinerson D, Goldman GA, Kitai E, Neri A. Women's attitudes towards menopause and hormone replacement therapy. Int J Gynecol Obstet 1996;54:271–7
- Israel Center for Disease Control. Women's Health in Israel 1999–2000: Data Book. Tel Aviv: Israel Center for Disease Control, 2001:49
- Ettinger B, Woods NF, Barrett-Connor E, Pressman A. The North American Menopause Society 1998 menopause survey: Part II. Counseling about hormone replacement therapy: association with socioeconomic status and access to medical care. Menopause 2000;7: 143–8
- Huston S, Sleath B, Rubin RH. Physician gender and hormone replacement therapy discussion. J Women's Health Gend Based Med 2001;10: 279–87
- Griffiths F. Women's decisions about whether or not to take hormone replacement therapy: influ-ence of social and medical factors. Br J Gen Pract 1995;45:477–80
- Roberts PJ, Sibbald B. Hormone replacement therapy: the views of general practitioners and practice nurses. Br J Gen Pract 2000;50:986–91
- Andersson K, Pedersen AT, Mattsson LA, Milsom I. Swedish gynecologists' and general practitioners' views on the climacteric period: knowledge, attitudes and management strategies. Acta Obstet Gynecol Scand 1998;77:909–16
- Brookdale Institute. Women's Health and Welfare in Israel: National Survey Findings. Jerusalem: Brookdale Institute, 2000:11–17
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestins in healthy postmenopausal women: principal results from Women's Health Initiative randomized controlled trial J Am Med Assoc 2002;288:321–33
- Matthews KA, Kuller LH, Wing RK, Meilahn EN, Plantinga P. Prior use of estrogen replace-ment therapy, are users healthier than nonusers? Am J Epidemiol 1996;143:971–8
- Mattsson LA, Stadberg E, Milsom I. Manage-ment of hormone replacement therapy: the Swedish experience. Eur J Obstet Gynecol Reprod Biol 1996;64(Suppl):83–5